Skinny Labels, Big Savings Act
Sponsor

Full profile: /officials/C001118
Source: Congress.gov · FEC
Cosponsors (4)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Committee Activity
Currently in
- House Committee on the JudiciaryReferred To · 2025-12-05
Previously
- Judiciary CommitteeReferred To · 2025-12-05
Plain-English Summary
Skinny Labels, Big Savings Act This bill provides a statutory safe harbor from patent infringement claims for generic or biosimilar manufacturers that seek or obtain approval for skinny labels of their drugs. Under current law, the Food and Drug Administration (FDA) may approve generic and biosimilar drugs through a process known as skinny labeling, which allows a generic manufacturer to seek approval only for approved uses of the drug that are no longer protected by patents. However, in GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc. , a court held that a generic manufacturer may sometimes be liable for patent infringement when it markets skinny label generics. The bill specifically lists the following as actions that are not considered infringement of a method of use claim in a patent under the Federal Food, Drug, and Cosmetic Act: submitting or seeking approval of a skinny label for a generic or biosimilar drug; promoting or commercially marketing a drug with skinny labeling approved by the FDA; or describing a drug product approved by the FDA as a generic of, or therapeutically equivalent to, the branded drug. The bill also applies the safe harbor to similar actions under the Public Health Service Act.
Plain-English rewrite of the Congressional Research Service summary published on Congress.gov. Cached and reviewed.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HR8787Servicemember Payment Data Privacy and Security ActReferred to Committee · 2026-05-13
- HR8570Cost Estimate Clarity ActReferred to Committee · 2026-04-29
- HR8569No Bias in the Baseline ActReferred to Committee · 2026-04-29
- HR7730Bankruptcy Threshold Adjustment Act of 2026Referred to Committee · 2026-03-26